Andréasson S, Allebeck P, Engström A, Rydberg U (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet ii, 1483–1486.
Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry 187, 510–515.
Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325, 1212–1213.
Castagnini A, Berrios GE (2009). Acute and transient psychotic disorders (ICD-10 F23): a review from a European perspective. European Archives of Psychiatry and Clinical Neuroscience 259, 433–443.
Chen K, Kandel DB (1995). The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health 85, 41–47.
David AS, Malmberg A, Brandt L, Allebeck P, Lewis G (1997). IQ and risk for schizophrenia: a population-based cohort study. Psychological Medicine 27, 1311–1323.
Foti DJ, Kotov R, Guey LT, Bromet EJ (2010). Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. American Journal of Psychiatry 167, 987–993.
Hall W, Degenhardt L (2004). Is there a specific ‘cannabis psychosis’? In Marihuana and Madness (ed. Castle D. and Murray R.), pp. 89–100. Cambridge University Press: Cambridge.
Hall W, Degenhardt L (2009). Adverse health effects of non-medical cannabis use. Lancet 374, 1383–1391.
Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM (2008). Gene–environment interplay between cannabis and psychosis. Schizophrenia Bulletin 34, 1111–1121.
Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB (2007). Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 102, 597–606.
Johns A (2001). Psychiatric effects of cannabis. British Journal of Psychiatry 178, 116–122.
Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J (2008). Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatrica Scandinavica 118, 209–213.
Kuepper R, van Os J, Lieb R, Wittchen HU, Hofler M, Henquet C (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. British Medical Journal 342, d738.
MacCoun R, Reuter P (1997). Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate. Science 278, 47–52.
Malmberg A, Lewis G, David A, Allebeck P (1998). Premorbid adjustment and personality in people with schizophrenia. British Journal of Psychiatry 172, 308–315.
McGrath J, Welham J, Scott J, Varghese D, Degenhardt L, Hayatbakhsh MR, Alati R, Williams GM, Bor W, Najman JM (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Archives of General Psychiatry 67, 440–447.
Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319–328.
Murray RM, Morrison PD, Henquet C, Di Forti M (2007). Cannabis, the mind and society: the hash realities. Nature Reviews Neuroscience 8, 885–895.
Nahas GG, Latour C (1993). Epidemiology. In Cannabis: Physiopathology, Epidemiology, Detection (ed. Nahas G. G. and Latour C.), pp. 193–273. CRC Press: Boca Raton, FL.
Smit F, Bolier L, Cuijpers P (2004). Cannabis use and the risk of later schizophrenia: a review. Addiction 99, 425–430.
Solowij N, Grenyer BF (2002). Are the adverse consequences of cannabis use age-dependent? Addiction 97, 1083–1086.
Thornicroft G (1990). Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry 157, 25–33.
van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319–327.
Winstock AR, Ford C, Witton J (2010). Assessment and management of cannabis use disorders in primary care. BMJ 340, c1571.
Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal 325, 1199.
Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2008). Effects of cannabis use on outcomes of psychotic disorders: systematic review. British Journal of Psychiatry 193, 357–363.